Cargando…
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899907/ https://www.ncbi.nlm.nih.gov/pubmed/35253379 http://dx.doi.org/10.15252/emmm.202115618 |
| _version_ | 1784664012160499712 |
|---|---|
| author | Ye, Liping Lin, Chuyong Wang, Xi Li, Qiji Li, Yue Wang, Meng Zhao, Zekun Wu, Xianqiu Shi, Dongni Xiao, Yunyun Ren, Liangliang Jian, Yunting Yang, Meisongzhu Ou, Ruizhang Deng, Guangzheng Ouyang, Ying Chen, Xiangfu Li, Jun Song, Libing |
| author_facet | Ye, Liping Lin, Chuyong Wang, Xi Li, Qiji Li, Yue Wang, Meng Zhao, Zekun Wu, Xianqiu Shi, Dongni Xiao, Yunyun Ren, Liangliang Jian, Yunting Yang, Meisongzhu Ou, Ruizhang Deng, Guangzheng Ouyang, Ying Chen, Xiangfu Li, Jun Song, Libing |
| author_sort | Ye, Liping |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8899907 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88999072022-03-11 Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer Ye, Liping Lin, Chuyong Wang, Xi Li, Qiji Li, Yue Wang, Meng Zhao, Zekun Wu, Xianqiu Shi, Dongni Xiao, Yunyun Ren, Liangliang Jian, Yunting Yang, Meisongzhu Ou, Ruizhang Deng, Guangzheng Ouyang, Ying Chen, Xiangfu Li, Jun Song, Libing EMBO Mol Med Corrigendum John Wiley and Sons Inc. 2022-03-07 2022-03-07 /pmc/articles/PMC8899907/ /pubmed/35253379 http://dx.doi.org/10.15252/emmm.202115618 Text en © 2022 The Authors. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Ye, Liping Lin, Chuyong Wang, Xi Li, Qiji Li, Yue Wang, Meng Zhao, Zekun Wu, Xianqiu Shi, Dongni Xiao, Yunyun Ren, Liangliang Jian, Yunting Yang, Meisongzhu Ou, Ruizhang Deng, Guangzheng Ouyang, Ying Chen, Xiangfu Li, Jun Song, Libing Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title_full | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title_fullStr | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title_full_unstemmed | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title_short | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer |
| title_sort | epigenetic silencing of sall2 confers tamoxifen resistance in breast cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899907/ https://www.ncbi.nlm.nih.gov/pubmed/35253379 http://dx.doi.org/10.15252/emmm.202115618 |
| work_keys_str_mv | AT yeliping epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT linchuyong epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT wangxi epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT liqiji epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT liyue epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT wangmeng epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT zhaozekun epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT wuxianqiu epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT shidongni epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT xiaoyunyun epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT renliangliang epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT jianyunting epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT yangmeisongzhu epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT ouruizhang epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT dengguangzheng epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT ouyangying epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT chenxiangfu epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT lijun epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer AT songlibing epigeneticsilencingofsall2conferstamoxifenresistanceinbreastcancer |